OR WAIT null SECS
May 12, 2023
In a deal potentially worth more than $530 million, Amgen will use TScan Therapeutics’ target discovery platform to home in on novel targets for Crohn’s disease treatment.
The new partnership between Sandoz, a Novartis division, and Just – Evotec Biologics will aim to develop and manufacture multiple biosimilars.
May 11, 2023
Critical raw materials supplier, Biosynth, has acquired UK-based Cambridge Research Biochemicals (CRB).
May 10, 2023
Private investors from Advent International and Warburg Pincus will operate the assets as an independent CDMO.
May 09, 2023
Boehringer Ingelheim will use Ginkgo’s metagenomic sequence database to identify potential lead molecules for diseases with high unmet patient needs.
May 03, 2023
Competition in the organ-on-a-chip market increases as NETRI enters the arena.
April 24, 2023
JMI Laboratories and bioMérieux will work to improve microbiology diagnostics tools.
April 18, 2023
Merck will acquire Prometheus Biosciences, a clinical-stage biotechnology company specializing in immune-mediated diseases, at a total equity valuation of $10.8 billion.
April 14, 2023
Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.
The acquisition of Cell Systems will bolster AnaBios’ portfolio of human tissue and cells for use in drug discovery.